Loading...
PhD Izidor Sosič

PhD Izidor Sosič
no.: 30816 source: ARIS

researcher – active in research organisation
Research activity

Code Science Field Subfield
1.09.00  Natural sciences and mathematics  Pharmacy   
Bibliography Representative bibliographic units | Personal| COBISS+
source: COBISS
source: SICRIS
Points
873.04
A''
164.98
A'
468.3
A1/2
721.64
CI10
1,436
CImax
84
h10
21
A1
3.23
A3
0.04
Data for the last 5 years (citations for the last 10 years) on July 11, 2024; A3 for period 2018-2022 (update for tender in 2023: YES)
Data for ARIS tenders ( 21.05.2024 – Target research programmes, archive )
Database Linked records Citations Pure citations Average pure citations
WoS 81  1,696  1,393  17.2 
Scopus 83  1,777  1,443  17.39 
Mentoring junior researchers
source: ARIS
no. Name and surname Type Period Code
1 Nika Strašek Benedik  Bologna doctoral studies  10/1/2020 - 9/30/2024  52378 
Doctoral dissertations and other final papers Show
Obtaining results now
source: COBISS
Employments
source: ARIS
Type of employment Research org. Research group
Full time employment (120%, RD:60%)  University of Ljubljana, Faculty of Pharmacy  Chair for Pharmaceutical Chemistry 
Research projects Legend
source: ARIS
no. Code Title Period Head No. of publications
1. N1-0331  A double whammy for the NF-κB signalling pathway: development of TAK1 and IKKβ degraders against inflammation-driven diseases   2024  PhD Izidor Sosič  260 
2. J1-50037  Development of CDK1-selective degraders for the treatment of T-cell malignancies   2023 - 2024  PhD Izidor Sosič  1,132 
3. J3-50116  Matters of the heart: elucidating the cardiotoxic mechanism of proteasome inhibitors   2023 - 2024  PhD Martina Gobec  2,239 
4. J1-4417  Development of novel small molecule Toll-like receptors 7 and 8 modulators for cancer immunotherapy   2022 - 2024  PhD Matej Sova  3,972 
5. J1-4402  Dynamical model of a type II DNA topoisomerase biological nanomachine and design of catalytic inhibitors   2022 - 2024  PhD Andrej Perdih  2,661 
6. J1-4400  Evaluation of transient protein states   2022 - 2024  PhD Simona Golič Grdadolnik  3,283 
7. J3-3079  Bactericidal nanoblades: a proof-of-concept approach for bimodal chemo-mechanical eradication of persistent biofilms   2021 - 2024  PhD Stane Pajk  2,444 
8. N1-0169  Kovalentni pristop k boju proti bakterijski rezistenci (Slovene)   2021 - 2023  PhD Stanislav Gobec  1,206 
9. J3-2517  Development of innate immune receptor-targeting chimeras as custom-tailored vaccine adjuvants   2020 - 2023  PhD Žiga Jakopin  2,252 
10. J1-2485  The kiss of death for key apoptosis players: development of BCL-2 and BAX PROTACs   2020 - 2023  PhD Izidor Sosič  987 
11. J1-1717  Development of novel Hsp90 inhibitors with anticancer activity   2019 - 2023  PhD Tihomir Tomašić  1,932 
12. J3-1745  Elucidating the role of immunoproteasome in platelet-driven immune response   2019 - 2023  PhD Martina Gobec  1,148 
13. Z1-7181  Optimization of nitroxoline-based inhibitors of cathepsin B as potential drugs for the treatment of cancer   2016 - 2017  PhD Izidor Sosič  260 
14. L1-6745  Combating bacterial resistance: optimisation of bacterial cell wall biosynthesis inhibitors   2014 - 2015  PhD Stanislav Gobec  3,275 
15. J1-6743  Computational tools development for modeling of pharmaceutically interesting molecules   2014 - 2015  PhD Dušanka Janežič  2,747 
16. J4-6811  The role of cysteine protease inhibitors in NK cell mediated lysis of tumour cells   2014 - 2015  PhD Janko Kos  2,471 
17. J4-5529  Nitroxoline and its derivatives as new antitumour drugs   2013 - 2015  PhD Janko Kos  6,004 
18. L1-4039  Preclinical development of new antibacterial drugs   2011  PhD Stanislav Gobec  4,197 
ARIS research and infrastructure programmes Legend
source: ARIS
no. Code Title Period Head No. of publications
1. P1-0208  Medicinal chemistry - drug design, synthesis and evaluation   2022 - 2024  PhD Stanislav Gobec  5,406 
2. P1-0208  Medicinal chemistry - drug design, synthesis and evaluation   2015 - 2021  PhD Stanislav Gobec  6,074 
3. P1-0208  Farmacevtska kemija: načrtovanje, sinteza in vrednotenje učinkovin (Slovene)   2009 - 2014  PhD Danijel Kikelj  5,947 
International projects
no. Code Title Period Head No. of publications
1. CELSA/23/038  Degradation of CDK1 and HDACs as a strategy to treat T-cell malignancies   10/1/2023 - 3/9/2025     
We were not given permission by the researcher to publish data.
Views history
Favourite